KIMBERLY BIGGERSTAFF: Open Payments
NPI 1669173688 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,883 in 312 payments from 20 companies in 2025. Trend: 2023 $2,323 · 2024 $4,973 · 2025 $4,883
Food & beverage: $4,874Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 85 | $1,350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 52 | $764 |
| Janssen Biotech, Inc. | 38 | $562 |
| Madrigal Pharmaceuticals | 27 | $500 |
| Ardelyx, Inc. | 24 | $334 |
| QOL Medical, LLC | 14 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $228 |
| Phathom Pharmaceuticals, Inc. | 11 | $161 |
| GENZYME CORPORATION | 7 | $152 |
| Aimmune Therapeutics, Inc. | 13 | $143 |
Products named: ENTYVIO, TREMFYA, RINVOQ, REZDIFFRA, IBSRELA, Sucraid, XIFAXAN, CREON.
Industry payments across IN — which companies pay providers there.
